Autocrine stimulation by erythropoietin in transgenic mice results in erythroid proliferation without neoplastic transformation

Blood Cells, Molecules, and Diseases

Volumn 30, Issue 1, 2003, Pages 82-89

  Madan, A ^a   Lin, C ^b   Wang, Z ^c   Curtin, P T ^c,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

5 HS 2; Autocrine stimulation; Erythropoietin; Polycythemia

Indexed keywords

BETA GLOBIN; ERYTHROPOIETIN; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BURST FORMING UNIT E; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; ERYTHROLEUKEMIA; GENE CONSTRUCT; GENE EXPRESSION; GENE INDUCTION; GENE LOCUS; HEMATOCRIT; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETICULOCYTE COUNT; RNA ANALYSIS; RNA ISOLATION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0037242691     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00016-0     Document Type: Article

References (63)

1. Jelkmann W. Erythropoietin structure, control of production, and function . Physiol. Rev. 72:1992;449-489.
2. Krantz S.B. Erythropoietin. Blood. 77:1991;419-434.
3. Koury M.J., Bondurant M.C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science. 248:1990;378-381.
4. Bondurant M.C., Koury M.J. Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol. Cell. Biol. 6:1986;2731-2733.
5. Sawyer S.T., Krantz S.B., Goldwasser E. Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells. J. Biol. Chem. 262:1987;5554-5562.
6. Ebert B.L., Bunn H.F. Regulation of the erythropoietin gene. Blood. 94:1999;1864-1877.
7. Beru N., McDonald J., Lacombe C., Goldwasser E. Expression of the erythropoietin gene. Mol. Cell. Biol. 6:1986;2571-2575.
8. Goldberg M.A., Gaut C.C., Bunn H.F. Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood. 77:1991;271-277.
9. Zanjani E.D., Poster J., Burlington H., Mann L.I., Wasserman L.R. Liver as the primary site of erythropoietin formation in the fetus. J. Lab. Clin. Med. 89:1977;640-644.
10. Blanchard K.L., Acquaviva A.M., Galson D.L., Bunn H.F. Hypoxic induction of the human erythropoietin gene cooperation between the promoter and enhancer, each of which contains steroid receptor response elements . Mol. Cell. Biol. 12:1992;5373-5385.
11. Madan A., Curtin P.T. A 24-base-pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc. Natl. Acad. Sci. USA. 90:1993;3928-3932.
12. Beck I., Ramirez S., Weinmann R., Caro J. O Enhancer element at the 3′-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. J. Biol. Chem. 266:1991;15563-15566.
13. Semenza G.L., Nejfelt M.K., Chi S.M., Antonarakis S.E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. USA. 88:1991;5680-5684.
14. Madan A., Lin C., Hatch S.L. 2nd., Curtin P.T. Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood. 85:1995;2735-2741.
15. Semenza G.L., Traystman M.D., Gearhart J.D., Antonarakis S.E. Polycythemia in transgenic mice expressing the human erythropoietin gene. Proc. Natl. Acad. Sci. USA. 86:1989;2301-2305.
16. Semenza G.L., Dureza R.C., Traystman M.D., Gearhart J.D., Antonarakis S.E. Human erythropoietin gene expression in transgenic mice multiple transcription initiation sites and cis-acting regulatory elements . Mol. Cell. Biol. 10:1990;930-938.
17. Semenza G.L., Koury S.T., Nejfelt M.K., Gearhart J.D., Antonarakis S.E. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc. Natl. Acad. Sci. USA. 88:1991;8725-8729.
18. Ney P.A., D'Andrea A.D. Friend erythroleukemia revisited. Blood. 96:2000;3675-3680.
19. Longmore G.D., Lodish H.F. An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice a cytokine receptor superfamily oncogene . Cell. 67:1991;1089-1102.
20. Showers M.O., DeMartino J.C., Saito Y., D'Andrea A.D. Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line. Mol. Cell. Biol. 13:1993;739-748.
21. Yoshimura A., Longmore G., Lodish H.F. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature. 348:1990;647-649.
22. Hino M., Tojo A., Misawa Y., Morii H., Takaku F., Shibuya M. Unregulated expression of the erythropoietin receptor gene caused by insertion of spleen focus-forming virus long terminal repeat in a murine erythroleukemia cell line. Mol. Cell. Biol. 11:1991;5527-5533.
23. Lacombe C., Chretien S., Lemarchandel V., Mayeux P., Romeo P.H., Gisselbrecht S., Cartron J.P. Spleen focus-forming virus long terminal repeat insertional activation of the murine erythropoietin receptor gene in the T3Cl-2 friend leukemia cell line. J. Biol. Chem. 266:1991;6952-6956.
24. D'Andrea A.D., Yoshimura A., Youssoufian H., Zon L.I., Koo J.W., Lodish H.F. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol. Cell. Biol. 11:1991;1980-1987.
25. Klingmuller U., Lorenz U., Cantley L.C., Neel B.G., Lodish H.F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729-738.
26. Shultz L.D., Schweitzer P.A., Rajan T.V., Yi T., Ihle J.N., Matthews R.J., Thomas M.L., Beier D.R. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Heph) gene. Cell. 73:1993;1445-1454.
27. Tsui H.W., Siminovitch K.A., de Souza L., Tsui F.W. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat. Genet. 4:1993;124-129.
28. Howard J.C., Berger L., Bani M.R., Hawley R.G., Ben-David Y. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity. Oncogene. 12:1996;1405-1415.
29. Tambourin P., Casadevall N., Choppin J., Lacombe C., Heard J.M., Fichelson S., Wendling F., Varet B. Production of erythropoietin-like activity by a murine erythroleukemia cell line. Proc. Natl. Acad. Sci. USA. 80:1983;6269-6273.
30. Li Q., Harju S., Peterson K.R., Fang X., Stamatoyannopoulos G. Locus control regions. Blood. 100:2002;3077-3086.
31. Tuan D., Solomon W., Li Q., London I.M. The "beta-like-globin" gene domain in human erythroid cells. Proc. Natl. Acad. Sci. USA. 82:1985;6384-6388.
32. Grosveld F., van Assendelft G.B., Greaves D.R., Kollias G. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell. 51:1987;975-985.
33. Blom van Assendelft G., Hanscombe O., Grosveld F., Greaves D.R. The beta-globin dominant control region activates homologous and heterologous promoters in a tissue-specific manner. Cell. 56:1989;969-977.
34. Curtin P.T., Liu D.P., Liu W., Chang J.C., Kan Y.W. Human beta-globin gene expression in transgenic mice is enhanced by a distant DNase I hypersensitive site. Proc. Natl. Acad. Sci. USA. 86:1989;7082-7086.
35. Ryan T.M., Behringer R.R., Townes T.M., Palmiter R.D., Brinster R.L. High-level erythroid expression of human alpha-globin genes in transgenic mice. Proc. Natl. Acad. Sci. USA. 86, 1989;37-41.
36. Garcia J.F., Ebbe S.N., Hollander L., Cutting H.O., Miller M.E., Cronkite E.P. Radioimmunoassay of erythropoietin circulating levels in normal and polycythemic human beings . J. Lab. Clin. Med. 99:1982;624-635.
37. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
38. Melton D.A., Krieg P.A., Rebagliati M.R., Maniatis T., Zinn K., Green M.R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nuc. Acids Res. 12:1984;7035-7056.
39. Gregory C.J. Erythropoietin sensitivity as a differentiation marker in the hemopoietic system studies of three erythropoietic colony responses in culture . J. Cell Physiol. 89:1976;289-301.
40. Miller C.L., Rebel V.I., Lemieux M.E., Helgason C.D., Lansdorp P.M., Eaves C.J. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Exp. Hematol. 24:1996;185-194.
41. Villeval J.L., Metcalf D., Johnson G.R. Fatal polycythemia induced in mice by dysregulated erythropoietin production by hematopoietic cells. Leukemia. 6:1992;107-115.
42. Jimenez G., Griffiths S.D., Ford A.M., Greaves M.F., Enver T. Activation of the beta-globin locus control region precedes commitment to the erythroid lineage. Proc. Natl. Acad. Sci. USA. 89:1992;10618-10622.
43. Tilbrook P.A., Bittorf T., Callus B.A., Busfield S.J., Ingley E., Klinken S.P. Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells. Cell. Growth Differ. 7:1996;511-520.
44. Yamamura Y., Senda H., Kageyama Y., Matsuzaki T., Noda M., Ikawa Y. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Mol. Cell. Biol. 18:1998;1172-1180.
45. Janowska-Wieczorek A., Majka M., Ratajczak J., Ratajczak M.Z. Autocrine/paracrine mechanisms in human hematopoiesis. Stem Cells. 19:2001;99-107.
46. Pech N., Hermine O., Goldwasser E. Further study of internal autocrine regulation of multipotent hematopoietic cells. Blood. 82:1993;1502-1506.
47. Sato T., Maekawa T., Watanabe S., Tsuji K., Nakahata T. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin. J. Clin. Invest. 106:2000;263-270.
48. Stopka T., Zivny J.H., Stopkova P., Prchal J.F., Prchal J.T. Human hematopoietic progenitors express erythropoietin. Blood. 91:1998;3766-3772., 49.
49. Spivak J.L. Erythrocytosis. 2000;Churchill Livingstone, Philadelphia.
50. Prchal J.T., Semenza G.L., Prchal Sokol L. Familial polycythemia. Science. 268:1995;1831-1832.
51. Kochling J., Curtin P.T., Madan A. Regulation of human erythropoietin gene induction by upstream flanking sequences in transgenic mice. Br. J. Haematol. 103:1998;960-968.
52. Wagner K.F., Katschinski D.M., Hasegawa J., Schumacher D., Meller B., Gembruch U., Schramm U., Jelkmann W., Gassmann M., Fandrey J. Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood. 97:2001;536-542.
53. Hamamori Y., Samal B., Tian J., Kedes L. Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA. Hum. Gene Ther. 5:1987;1349-1356.
54. Muramatsu T., Arakawa S., Fukazawa K., Fujiwara Y., Yoshida T., Sasaki R., Masuda S., Park H.M. In vivo gene electroporation in skeletal muscle with special reference to the duration of gene expression. Int. J. Mol. Med. 7:2001;37-42.
55. Tripathy S.K., Goldwasser E., Lu M.M., Barr E., Leiden J.M. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA. 91:1994;11557-11561.
56. Tripathy S.K., Svensson E.C., Black H.B., Goldwasser E., Margalith M., Hobart P.M., Leiden J.M. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. USA. 93:1996;10876-10880.
57. Zoltick P.W., Chirmule N., Schnell M.A., Gao G.P., Hughes J.V., Wilson J.M. Biology of E1-deleted adenovirus vectors in nonhuman primate muscle. J. Virol. 75:2001;5222-5229.
58. Ye X., Rivera V.M., Zoltick P., Cerasoli F. Jr., Schnell M.A., Gao G., Hughes J.V., Gilman M., Wilson J.M. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science. 283:1991;88-89.
59. Hamamori Y., Samal B., Tian J., Kedes L. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J. Clin. Invest. 95:1995;1808-1813.
60. Osada S., Ebihara I., Setoguchi Y., Takahashi H., Tomino Y., Koide H. Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene. Kidney Int. 55:1999;1234-1240.
61. Rizzuto G., Cappelletti M., Mennuni C., Wiznerowicz M., DeMartis A., Maione D., Ciliberto G., La Monica N., Fattori E. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum. Gene Ther. 11:1995;1891-1900.
62. Bohl D., Bosch A., Cardona A., Salvetti A., Heard J.M. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle. Blood. 95:2000;2793-2798.
63. Villeval J.L., Rouyer-Fessard P., Blumenfeld N., Henri A., Vainchenker W., Beuzard Y. Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine beta-thalassemia. Blood. 84:1994;928-933.